The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy

BACKGROUND: Ovarian cancer has the highest mortality rate of the gynaecological cancers. Although cisplatin (CDDP) is an effective treatment for ovarian cancer, recurrence is frequent and leads to death. The objective was to explore the role and possible mechanisms of platelet-activating factor rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Y, Zhang, X, Hong, S, Zhang, M, Cai, Q, Jiang, W, Xu, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119987/
https://www.ncbi.nlm.nih.gov/pubmed/24921917
http://dx.doi.org/10.1038/bjc.2014.323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119987/
https://www.ncbi.nlm.nih.gov/pubmed/24921917
http://dx.doi.org/10.1038/bjc.2014.323

Ejemplares similares